Skip to main content
Caplight Logo









S2N Health

S2N Health

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://s2nhealth.com/

Last Round

Seed

Jun 2, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

S2N Health is a software and consulting company that provides an AI-powered commercial intelligence platform and strategic services for the medtech industry.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence, Medical Devices, Sales Enablement, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

commercial intelligencemedtechgo-to-market strategysales enablementrevenue intelligenceAI sales toolmedtech consultingvertical SaaShealthcare analyticscustomer targetingdigital healthdiagnosticsCRM integrationSalesforce integrationM&A strategy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

S2N Health Comparables

Compare S2N Health with similar companies based on industry and business-model similarity.

S2N Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alpha Sophia
83%
MedScout
82%
AcuityMD
80%

S2N Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 2, 2026
VC RoundAug 11, 2025
SeedMay 23, 2024

Key People

Founding team and executive leadership

Tim Kofol

Chief Technology Officer, Principal

Executive Team

Leah Shea

Chief Product Officer

Executive Team

S2N Health Investors

Notable investors and investment history

S2N Health investors
InvestorRounds
Robin Hood VenturesSeed, VC Round
Excelerate Health VenturesVC Round, Seed
Boston Millennia PartnersSeed, VC Round
Rittenhouse VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2026

    Raised $3M in a Seed Round.

  • Jan 2, 2026

    Monthly visitors grew 160% MoM, reaching 1.4K.

S2N Health Filings

Explore SEC and related filing metadata, where available.

S2N Health filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about S2N Health's valuation, stock price, and market status.

Is S2N Health a public or private company?

S2N Health is a private company.

What is the current stock price of S2N Health?

S2N Health is a private company with no public stock price. No recent secondary market data is available.

How much is S2N Health worth (valuation)?

Valuation information for S2N Health is not publicly available.

Can I buy S2N Health stock?

S2N Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was S2N Health's last funding round?

S2N Health's most recent funding round was Seed on June 2, 2026.

Who are the main investors in S2N Health?

Key investors in S2N Health include Excelerate Health Ventures.

Will S2N Health IPO soon?

No public IPO plans have been announced for S2N Health.

How can I track S2N Health secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor S2N Health's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range30
Year Founded2011
Last FundingJun 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?